Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Comparative study between Ondansetron and Dexamethasone in Post-operative Nausea Vomiting (PONV)

View through CrossRef
Background: Postoperative nausea and vomiting (PONV) is a frequent and distressing complication following anaesthesia and surgery that negatively affects patient comfort, delays recovery, and may prolong hospital stay. Ondansetron and dexamethasone are commonly used antiemetic agents; however, their comparative efficacy in PONV prevention remains clinically important. Objective: To compare the efficacy and safety of ondansetron and dexamethasone in preventing postoperative nausea and vomiting. Materials and Methods: This comparative observational study included 74 patients undergoing elective surgery under anaesthesia. Patients were equally allocated into two groups: Group A (n=37) received ondansetron and Group B (n=37) received dexamethasone for PONV prophylaxis. Demographic and intra-operative parameters were assessed. Postoperative outcomes including nausea, retching, vomiting, complete response, rescue antiemetic requirement, and adverse effects were evaluated at 0–3, 3–6, 6–9, 9–12, and 12–24 hours after surgery. Statistical analysis was performed with significance considered at p<0.05. Results: Baseline demographic and intra-operative characteristics were comparable between groups (p>0.05). Group B showed significantly lower incidences of nausea, retching, and vomiting during the early postoperative period (0–3 and 3–6 hours) compared with Group A (p<0.05). The complete response rate was significantly higher in Group B during early recovery and remained superior at 6–9 hours (83.78% vs. 59.46%, p=0.016). No significant differences were observed during 9–24 hours. Rescue antiemetic requirements and adverse effects, including headache, dizziness, and hypotension, were similar between groups. Conclusion: Dexamethasone provided better early postoperative control of PONV than ondansetron with a comparable safety profile, suggesting its effectiveness as a prophylactic antiemetic agent.
Title: Comparative study between Ondansetron and Dexamethasone in Post-operative Nausea Vomiting (PONV)
Description:
Background: Postoperative nausea and vomiting (PONV) is a frequent and distressing complication following anaesthesia and surgery that negatively affects patient comfort, delays recovery, and may prolong hospital stay.
Ondansetron and dexamethasone are commonly used antiemetic agents; however, their comparative efficacy in PONV prevention remains clinically important.
Objective: To compare the efficacy and safety of ondansetron and dexamethasone in preventing postoperative nausea and vomiting.
Materials and Methods: This comparative observational study included 74 patients undergoing elective surgery under anaesthesia.
Patients were equally allocated into two groups: Group A (n=37) received ondansetron and Group B (n=37) received dexamethasone for PONV prophylaxis.
Demographic and intra-operative parameters were assessed.
Postoperative outcomes including nausea, retching, vomiting, complete response, rescue antiemetic requirement, and adverse effects were evaluated at 0–3, 3–6, 6–9, 9–12, and 12–24 hours after surgery.
Statistical analysis was performed with significance considered at p<0.
05.
Results: Baseline demographic and intra-operative characteristics were comparable between groups (p>0.
05).
Group B showed significantly lower incidences of nausea, retching, and vomiting during the early postoperative period (0–3 and 3–6 hours) compared with Group A (p<0.
05).
The complete response rate was significantly higher in Group B during early recovery and remained superior at 6–9 hours (83.
78% vs.
59.
46%, p=0.
016).
No significant differences were observed during 9–24 hours.
Rescue antiemetic requirements and adverse effects, including headache, dizziness, and hypotension, were similar between groups.
Conclusion: Dexamethasone provided better early postoperative control of PONV than ondansetron with a comparable safety profile, suggesting its effectiveness as a prophylactic antiemetic agent.

Related Results

Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct Introduction Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Torsades de Pointes Following Ondansetron Administration: A Case Report with literature review
Torsades de Pointes Following Ondansetron Administration: A Case Report with literature review
Abstract Introduction Ondansetron blocks human ether-à-go-go-related gene (hERG) potassium channels, causing QT prolongation and risk of torsades de pointes (TdP). Despite its wide...
Dexamethasone is cost-effective alternative to ondansetron in preventing Post-Operative Nausea and Vomiting
Dexamethasone is cost-effective alternative to ondansetron in preventing Post-Operative Nausea and Vomiting
Background: Postoperative nausea and vomiting (PONV) is a common complication of anesthesia and surgery. Numerous anti-emetics have been studied to prevent and treat PONV. Methods...
Gambaran kejadian postoperative nausea vomiting (PONV) pada pasien general dan regional anestesi
Gambaran kejadian postoperative nausea vomiting (PONV) pada pasien general dan regional anestesi
Background: Postoperative nausea and vomiting (PONV) is a common complication after anesthetic procedures, both general and regional. This condition can cause discomfort, prolong r...
Effect of Ondansetron and Dexamethasone to Prevent Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Cholecystectomy
Effect of Ondansetron and Dexamethasone to Prevent Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Cholecystectomy
Background: Postoperative nausea and vomiting (PONV) remains a significant challenge following laparoscopic cholecystectomy, often prolonging hospital stay and impacting patient re...

Back to Top